Paradoxical role of β8 integrin on angiogenesis and vasculogenic mimicry in glioblastoma

• Published in: Cell death & disease Vol. 13; no. 6; p. 536
• Main Authors: Liu, Yang, Xu, Xiangdong, Zhang, Yuxuan, Mo, Yunzhao, Sun, Xinlin, Shu, Lingling, Ke, Yiquan
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 08-06-2022; Springer Nature B.V; Nature Publishing Group
• Subjects: 13/1; 13/100; 14/35; 631/532/71; 631/67/1922; 64/60; Angiogenesis; Animals; Antibodies; Biochemistry; Biomedical and Life Sciences; Brain cancer; Brain tumors; Cell Biology; Cell Culture; Cell Line, Tumor; Cholecystokinin; Endothelial cells; Endothelial Cells - metabolism; Glioblastoma; Glioblastoma - pathology; Glioma - pathology; Glioma cells; Humans; Hypoxia; Immunology; Integrin beta Chains; Invasiveness; Life Sciences; Mesenchyme; Mice; Mice, Nude; Microvasculature; Mimicry; Neovascularization, Pathologic - metabolism; RhoA protein; Smad2 protein; Stem cells; Transforming growth factor-b1; Vascularization
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-022-04959-7

Glioblastoma multiforme (GBM) is the most aggressive and highly vascularized brain tumor with poor prognosis. Endothelial cell-dependent angiogenesis and tumor cell-dependent Vasculogenic mimicry (VM) synergistically contribute to glioma vascularization and progression. However, the mechanism underlying GBM vascularization remains unclear. In this study, GBM stem cells (GSCs) were divided into high and low β8 integrin (ITGB8) subpopulations. Co-culture assays followed by Cell Counting Kit-8 (CCK-8), migration, Matrigel tube formation, and sprouting assays were conducted to assess the proliferative, migratory and angiogenic capacity of GBM cells and human brain microvascular endothelial cells (hBMECs). An intracranial glioma model was constructed to assess the effect of ITGB8 on tumor vascularization in vivo. Our results indicated that ITGB8 expression was elevated in GSCs and positively associated with stem cell markers in glioma tissues, and could be induced by hypoxia and p38 activation. ITGB8 in GSCs inhibited the angiogenesis of hBMECs in vitro, while it promoted the ability of network formation and expression of VM-related proteins. The orthotopic GBM model showed that ITGB8 contributed to decreased angiogenesis, meanwhile enhanced invasiveness and VM formation. Mechanistic studies indicated that ITGB8-TGFβ1 axis modulates VM and epithelial-mesenchymal transition (EMT) process via Smad2/3-RhoA signaling. Together, our findings demonstrated a differential role for ITGB8 in the regulation of angiogenesis and VM formation in GBM, and suggest that pharmacological inhibition of ITGB8 may represent a promising therapeutic strategy for treatment of GBM.